Three-pronged attack can overcome drug resistance in bowel cancer 25 Mar 2019 Researchers at the ICR show that triple drug combinations could prevent resistance in many cancer types. Find out more Show/Hide
ICR researchers among the world’s most influential 20 Mar 2019 Researchers at the ICR and The Royal Marsden have been named in a list of the world's most influential researchers. Find out more Show/Hide
New cancer drugs taking longer to reach NHS patients 04 Dec 2018 NHS patients are waiting longer for new cancer drugs because of delays in taking them through clinical trials and getting them approved for use, a major new analysis of regulatory data reveals. Find out more Show/Hide
The ICR responds to decision by NICE not to recommend abiraterone as first-line treatment for advanced prostate cancer 06 Jun 2018
New resource to challenge widespread poor practice in biomedical researchers’ use of chemical probes 12 Dec 2017
European Medicines Agency approves abiraterone combined with hormone therapy as first-line treatment for advanced prostate cancer 22 Nov 2017